Investing Profile

Jenny Rooke

InvestorVC
Managing Director at Genoa Ventures
genoavc.com/jennySan Francisco, California
Photo of Jenny Rooke, Managing Director at Genoa Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
NewCo Network
1585 CONNECTIONS
NewCo Network
1585 CONNECTIONS
NewCo Network
1585 CONNECTIONS
University of Washington Applied Physics Laboratory Network
842 CONNECTIONS
University of Washington Applied Physics Laboratory Network
842 CONNECTIONS
cb
Genoa Ventures Managing Director
$250K - $10.0M
$2.0M
28
$26.5M
CompanyStageDateRound SizeTotal Raised
Tropic Biosciences
Series CMar 2026$110M
Series BJun 2020$29M
$130M
BrightSpec
Series CDec 2022$18M
$18M
Bond Pet Foods
Series AJun 2022$18M
$18M
Meiogenix
Series ADec 2021$12M
$12M
InterVenn
Series CAug 2021$200M
Series BNov 2020$34M
Series UnknownDec 2018$9M
$240M
Co-investors: Adam D'Augelli (True Ventures), Sunil Dhaliwal (Amplify Partners)
Ionpath
Series BSep 2020$18M
Series AJan 2018
SeedOct 2015
$18M
Intabio
Series BFeb 2020$18M
Series AOct 2018$10M
SeedSep 2017$2M
$30M
NanoCellect Biomedical
Series BNov 2017$10M
$10M
Synthetic biology, DNA, RNA, protein, multiplexing; Research tools, diagnostics, applied sensors; Biology beyond healthcare; Automation, DBT; Experienced operators; Chimeric founders
Therapeutics; Digital health (pure digital, no wet biology or chem); Uncapped convertible notes
Investor, Board Observer Fellow2023 - Present
Investor, Director BrightSpec, Inc.2022 - Present
Investor, Board Observer General Inception2022 - Present
Investor Redux Bio2021 - Present
Investor, Director Stemson Therapeutics2021 - Present
Investor, Director Meiogenix2021 - Present
Investor, Director Aqtual, Inc.2021 - Present
Investor Tropic2020 - Present
Member Board of Trustees The Jackson Laboratory2019 - Present
Investor, Chair of the Board InterVenn Biosciences2018 - Present
Advisor Bill & Melinda Gates Foundation2016 - Present
Investor Ionpath Inc.2015 - Present
Managing Director Genoa Ventures2012 - Present
Managing Director Genoa Ventures Part-timePresent
Investor, Board Observer Ionpath Inc.Present
Venture Partner F-Prime CapitalPresent
Advisor GATES FOUNDATIONPresent
Investor IonpathPresent
Investor ZymergenPresent
Investor, Director NewCoPresent
Venture Partner F-PrimePresent
Board of Directors NewCoPresent
Investor, Advisor Bio-TechnePresent
Senior Program Officer, Global Health Discovery GATES FOUNDATIONPresent
Associate, Kauffman Fellow NewCoPresent
VP Corporate Development US GenomicsPresent
VP Research & Development / CSO US GenomicsPresent
Director, Business Development / Director of Collaborative R&D US GenomicsPresent
Engagement Manager McKinsey & CompanyPresent
Investor, Director University of Washington Applied Physics LaboratoryPresent
Board of Directors University of Washington Applied Physics LaboratoryPresent
Associate, Kauffman Fellow University of Washington Applied Physics LaboratoryPresent
Investor Zymergen, Inc.2014 - 2022
Investor, Director Intabio2017 - 2020
Advisor Caribou Biosciences2016 - 2020
Board Member Kauffman Fellows2009 - 2020
Venture Partner F-Prime Capital Partners2013 - 2017
Venture Partner Anterra Capital2016 - 2017
Board of Directors Cytek Biosciences2015 - 2016
Board of Directors Caribou Biosciences2014 - 2016
Investor, Advisor Zephyrus Biosciences2014 - 2016
Senior Program Officer, Global Health Discovery Bill & Melinda Gates Foundation2008 - 2012
Associate, Kauffman Fellow Fidelity Biosciences2006 - 2008
VP Corporate Development U.S. Genomics2005 - 2006
VP Research & Development / CSO U.S. Genomics2004 - 2005
Director, Business Development / Director of Collaborative R&D U.S. Genomics2001 - 2004
Engagement Manager McKinsey & Co1998 - 2001
Yale University Doctor of Philosophy (PhD) Genetics
Georgia Institute of Technology BS Physics
Yale University Ph.D. Genetics